These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 35634481)

  • 1. A Novel Hypoxia-Related Gene Signature with Strong Predicting Ability in Non-Small-Cell Lung Cancer Identified by Comprehensive Profiling.
    Yang H; Wang Z; Gong L; Huang G; Chen D; Li X; Du F; Lin J; Yang X
    Int J Genomics; 2022; 2022():8594658. PubMed ID: 35634481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
    Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
    World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNA-Associated Competing Endogenous RNA Network and Prognostic Nomogram for Patients With Colorectal Cancer.
    Song W; Fu T
    Front Oncol; 2019; 9():1181. PubMed ID: 31781492
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of Differentially Expressed Circular RNAs as miRNA Sponges in Lung Adenocarcinoma.
    Liu Y; Wang X; Bi L; Huo H; Yan S; Cui Y; Cui Y; Gu R; Jia D; Zhang S; Cai L; Li X; Xing Y
    J Oncol; 2021; 2021():5193913. PubMed ID: 34539783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for lung adenocarcinoma.
    Gao L; Zhang L
    BMC Cancer; 2021 Jul; 21(1):849. PubMed ID: 34301211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma.
    Yue C; Ma H; Zhou Y
    PeerJ; 2019; 7():e8128. PubMed ID: 31803536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of Circular RNA-MicroRNA-Messenger RNA Regulatory Network of Recurrent Implantation Failure to Explore Its Potential Pathogenesis.
    Luo J; Zhu L; Zhou N; Zhang Y; Zhang L; Zhang R
    Front Genet; 2020; 11():627459. PubMed ID: 33664765
    [No Abstract]   [Full Text] [Related]  

  • 9. A Novel circRNA-miRNA-mRNA Hub Regulatory Network in Lung Adenocarcinoma.
    Zuo H; Li X; Zheng X; Sun Q; Yang Q; Xin Y
    Front Genet; 2021; 12():673501. PubMed ID: 34306017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of lncRNA/circRNA-miRNA-mRNA ceRNA Network as Biomarkers for Hepatocellular Carcinoma.
    Chen S; Zhang Y; Ding X; Li W
    Front Genet; 2022; 13():838869. PubMed ID: 35386284
    [No Abstract]   [Full Text] [Related]  

  • 11. A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma.
    Liu XX; Yang YE; Liu X; Zhang MY; Li R; Yin YH; Qu YQ
    J Transl Med; 2019 Feb; 17(1):50. PubMed ID: 30777071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of circRNA-miRNA-mRNA network and identification of novel potential biomarkers for non-small cell lung cancer.
    Yang J; Hao R; Zhang Y; Deng H; Teng W; Wang Z
    Cancer Cell Int; 2021 Nov; 21(1):611. PubMed ID: 34801043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Enzalutamide Resistance-Related circRNA-miRNA-mRNA Regulatory Networks in Patients with Prostate Cancer.
    Yu J; Sun S; Mao W; Xu B; Chen M
    Onco Targets Ther; 2021; 14():3833-3848. PubMed ID: 34188491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of differentially expressed mRNAs as novel predictive biomarkers for gastric cancer diagnosis and prognosis.
    Zhou JW; Zhang YB; Huang ZY; Yuan YP; Jin J
    World J Gastrointest Oncol; 2024 May; 16(5):1947-1964. PubMed ID: 38764850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma.
    Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA
    Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of
    Lin H; Wang J; Shi Q; Wu M
    PeerJ; 2024; 12():e17338. PubMed ID: 38708353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma.
    Yang K; Wang F; Li K; Peng G; Yang H; Xu H; Xiang Y; Sun H
    Technol Cancer Res Treat; 2022; 21():15330338221085354. PubMed ID: 35422168
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification and integrated analysis of hepatocellular carcinoma-related circular RNA signature.
    Wang F; Xu X; Zhang N; Chen Z
    Ann Transl Med; 2020 Mar; 8(6):294. PubMed ID: 32355738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.
    Tan J; Wang W; Song B; Song Y; Meng Z
    Biomed Res Int; 2020; 2020():2837906. PubMed ID: 32802839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.